Inulin as a Carrier for Contrast Agents in Magnetic Resonance Imaging
摘要:
Magnetic resonance angiography (MRA) has put forth an impetus for the development of macromolecular Gd-III complexes that have a prolonged lifetime in the vascular system. Herein, we report the synthesis and Gd-III complexation of a new sugar conjugate based on inulin and the DO3A ligand (DO3A = 1,4,7,10-tetraazacyclododecan1,4,7-triacetic acid). Two API-DO3ASQ conjugates (API = 0-(aminopropyl)inulin, SQ = squaric acid = 3,4-dihydroxy-3cyclobutene-1,2-dione) with different degrees of substitution (ds=0.7 and ds=1.5) were prepared from API by using the diethyl ester of squaric acid as a linking agent for the DO3A chelate. The efficacies of the resulting Gd-III compounds were evaluated by investigation of their water H-1 longitudinal- relaxation-rate enhancements at variable field (NMRD). A dramatic increase in relaxivity was observed in the more highly substituted conjugate (ds = 1.5); this prompted us to do a variable-temperature 170 study in order to further characterize the relaxation parameters involved in this system. [Gd(APIDO3ASQ)] shows promising properties for application as a contrast agent for MRI.
The present invention relates to novel imaging probes and methods for using the probes in diagnostic imaging processes and other imaging processes to determine physiological functions.
本发明涉及新型成像探针以及使用这些探针在诊断成像过程和其他成像过程中确定生理功能的方法。
US6911457B2
申请人:——
公开号:US6911457B2
公开(公告)日:2005-06-28
[EN] NOVEL DIABETES IMAGING PROBES<br/>[FR] NOUVELLES SONDES D'IMAGERIE DE DIABETE
申请人:CARBOMER
公开号:WO2003086563A2
公开(公告)日:2003-10-23
The present invention relates to fluorinated or paramagnetic anti-diabetes probes and methods for using the probes in diagnostic imaging processes and other imaging processes to determine physiological functions.